Pathophysiological findings of early mind harm in people haven’t permitted conclusive determinations. We explored the essence of this phenomenon by taking intraoperative cortical specimens of Hunt-Kosnik grades IV~V (poor-grade) subarachnoid hemorrhages (SAH). From 2013 to 2017, we handled 39 consecutive poor-grade sufferers in 226 instances of aneurysmal SAH. Fourteen of the 39 sufferers agreed to this examine following written knowledgeable consent. We took specimens from untouched areas previous to surgical intervention: cortex close to the ruptured aneurysm for clipping, convexity cortex for cerebral ventricular drainage. Cortical specimens have been stained with hematoxylin-eosin, anti-cleaved <em>caspase</em>-3, and anti-DNA/RNA injury staining. Optimistic alerts have been calculated in six random, high-power fields for quantitative evaluation.
Double immunofluorescence was finished to judge neural injury. Chi-square analyses have been carried out to evaluate the correlation between the Glasgow End result Scale at 90 days after the ictus and the variety of constructive cells. Cortical specimens have been taken at 12.7 ± 7.00 h after the primary ictus. All <em>14</em> instances confirmed dense nuclei, with the looks of acidic and shrunken cytoplasms. Diffuse positivity of anti-cleaved <em>caspase</em>-Three and anti-DNA/RNA injury was detected. Cleaved <em>caspase</em>-Three was detected in 68% of neurons, and DNA/RNA injury was detected in 64% of neurons. Optimistic reactions of each antibodies indicated poor consequence.
With poor-grade instances, irreversible ischemic, apoptotic, and oxidative adjustments have been detected within the cerebral cortex inside a number of hours after the ictus. These adjustments occurred removed from the aneurysm. Our findings recommend {that a} revolution is required within the remedy technique for poor-grade SAH.
Thymus algeriensis and Thymus fontanesii exert neuroprotective impact towards power constriction injury-induced neuropathic ache in rats
We’ve beforehand demonstrated that the Thymus algeriensis and Thymus fontanesii extracts have highly effective anti-inflammatory, antipyretic, and analgesic results towards acute ache fashions. We profiled their chemical composition and located many phenolic acids, flavonoids, and phenolic diterpenes. On this work, we investigated their antioxidant properties on HaCaT cells uncovered to UVA-induced oxidative stress and examined their results towards power neuropathic ache and the underlying mechanisms. Via a rat power constriction harm (CCI) mannequin, we induced power neuropathic ache by inserting Four unfastened ligatures round the precise sciatic nerve for <em>14</em> days. Thermal and mechanical hyperalgesia along with chilly and dynamic allodynia have been examined on the day earlier than surgical procedure and on the seventh and <em>14</em>th post-surgery days.
Key markers of the nitrosative and oxidative stresses, along with markers of irritation, have been measured at day <em>14</em> submit surgical procedure. Histopathological examination and immunostaining of each synaptophysin and <em>caspase</em>-Three of sciatic nerve and mind stem have been additionally carried out. Outcomes of this examine confirmed that T. algeriensis extract suppresses UVA oxidative stress in HaCaT cells through activation of the Nrf-2 pathway. Each extracts attenuated hyperalgesia and allodynia at 7- and <em>14</em>-days post-surgery with extra distinguished results at day <em>14</em> of surgical procedure. Their protecting results towards neuropathic ache have been mediated by inhibiting NOX-1, iNOS, by growing the enzyme exercise of catalase, and inhibition of inflammatory mediators, NF-κB, TNF-α, lipoxygenase, COX-2 enzymes, and PGE2.
Moreover, they improved deleterious structural adjustments of the brainstem and sciatic nerve. Additionally they attenuated the elevated <em>caspase</em>-Three and synaptophysin. The info point out that each extracts have neuroprotective results towards power constriction injury-induced neuropathic ache. The noticed protecting results are partially mediated by means of attenuation of oxidative and nitrosative stress and suppression of each neuroinflammation and neuronal apoptosis, suggesting substantial actions of each extracts in amelioration of painful peripheral neuropathy.

Irreversible Neuronal Damage Begins Just After Aneurysm Rupture in Poor-Grade Subarachnoid Hemorrhage Patients
Results of gestational publicity to perfluorooctane sulfonate on the lung growth of offspring rats
Perfluorooctane sulfonate (PFOS) is a man-made fluorosurfactant broadly utilized in business and client merchandise. Earlier research with rats instructed that gestational publicity to PFOS could have an effect on the lung growth within the offspring. The mechanism, nevertheless, continues to be unknown. Within the current examine, we’ve uncovered 24 pregnant SD rats from gestational day 12-18 to totally different doses of PFOS (0, 1 or 5 mg/kg BW/day). The lungs of the offspring have been analyzed at postnatal days 1, 3, 7 and <em>14</em>. PFOS remedy appeared to cut back the alveolar numbers, leading to simplified alveolar construction and thickened alveolar septa. Additionally, PFOS handled animals had elevated lung irritation with up-regulated inflammasome related proteins NLRP3, ASC, <em>Caspase</em>-1 and GSDMD and elevated inflammatory cytokines IL-18 and IL-1β.
On the similar time, HIF-1α and VEGFA have been considerably down-regulated. Since HIF-1α and VEGFA are essential components selling alveolar growth and pulmonary angiogenesis, these outcomes instructed that PFOS can also have an effect on lung growth by inhibiting HIF-1α and VEGFA expression. Our outcomes right here point out that gestational publicity to PFOS could have an effect on lung growth within the offspring with pathological traits just like bronchopulmonary dysplasia (BPD), a extreme lung developmental defect. The outcomes additionally recommend that environmental components equivalent to PFOS could contribute to the growing incidence of developmental lung ailments, equivalent to BPD, by elevating lung irritation and inhibiting lung growth.
Adversarial results of fetal publicity of electronic-cigarettes and high-fat weight loss plan on male neonatal hearts
Epidemiological research have proven an elevated threat of cardiovascular ailments in kids born to moms who smoked throughout being pregnant. The cardiovascular threat within the offspring related to in utero nicotine publicity is additional exaggerated by maternal weight problems. The consumption of digital cigarettes (e-cigarettes) is alarmingly growing amongst adolescents and younger adults with out the information of their dangerous well being results. There has additionally been a considerable enhance in e-cigarette use by ladies of reproductive age. This examine investigates the detrimental results of gestational publicity of e-cigarette and a high-fat weight loss plan (HFD) on neonatal hearts.
Time-mated pregnant mice have been fed a HFD and uncovered to saline or e-cigarette aerosol with 2.4% nicotine from embryonic day 4 (E4) to E20. We demonstrated that in utero publicity of e-cigarettes and HFD from E4 to E20 triggers cardiomyocyte (CM) apoptosis within the offspring at postnatal day1 (PND1), PND3, and PND<em>14</em>. Induction of CM apoptosis following gestational publicity of e-cigarettes and HFD was related to inactivation of AMP-activated protein kinase (AMPK), elevated cardiac oxidative stress coupled with perturbation of cardiac BAX/BCL-2 ratio and activation of <em>caspase</em> Three at PND <em>14</em>.
Caspase-14 Antibody |
3011-30T |
Biovision |
each |
EUR 175.2 |
Caspase-14 Antibody |
49263-50ul |
SAB |
50ul |
EUR 286.8 |
Caspase-14 Antibody |
49263-100ul |
SAB |
100ul |
EUR 399.6 |
Caspase-14 Antibody |
R31216 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Caspase 14 is an enzyme that in humans is encoded by the CASP14 gene. CASP14 belongs the evolutionarily conserved caspase family. CASP14 was assigned to chromosome 19p13.1. Using Northern blot and semiquantitative RT-PCR analyses, it was showed that CASP14 was transcriptionally upregulated during maintenance of confluent cultures of human epidermal keratinocytes. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. Caspase 14 seems to play a role in keratinocyte differentiation and cornification and probably regulates maturation of the epidermis by proteolytically processing filaggrin. |
Caspase-14 Antibody |
E18-9035-1 |
EnoGene |
50ug/50ul |
EUR 145 |
Description: Available in various conjugation types. |
Caspase-14 Antibody |
E18-9035-2 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Polyclonal Caspase-14 Antibody |
APR00002G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-14 . This antibody is tested and proven to work in the following applications: |
Polyclonal Caspase-14 Antibody |
APR06296G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Caspase-14 . This antibody is tested and proven to work in the following applications: |
Caspase 14 (CASP14) Antibody |
20-abx171604 |
Abbexa |
|
|
|
Caspase 14 (CASP14) Antibody |
20-abx171605 |
Abbexa |
|
|
|
Caspase 14 (CASP14) Antibody |
20-abx211312 |
Abbexa |
|
|
|
Caspase 14 (CASP14) Antibody |
20-abx100900 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1362.00
-
EUR 661.20
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Caspase 14 (CASP14) Antibody |
20-abx128917 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1328.40
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Caspase 14 (CASP14) Antibody |
20-abx129522 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1362.00
-
EUR 661.20
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Caspase 14 (CASP14) Antibody |
20-abx130380 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Caspase 14 (CASP14) Antibody |
20-abx323896 |
Abbexa |
|
|
|
Caspase 14 (CASP14) Antibody |
20-abx320171 |
Abbexa |
|
|
|
Caspase 14 (CASP14) Antibody |
20-abx339598 |
Abbexa |
|
|
|
Caspase 14 (CASP14) Antibody |
20-abx005020 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Caspase 14 p10 antibody |
70R-50903 |
Fitzgerald |
100 ul |
EUR 292.8 |
Description: Purified Polyclonal Caspase 14 p10 antibody |
Caspase 14 p10 Antibody |
20-abx008233 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Caspase-14 Conjugated Antibody |
C49263 |
SAB |
100ul |
EUR 476.4 |
Caspase-14 Polyclonal Antibody |
ABP50016-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of Caspase-14 from Human. This Caspase-14 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase-14 at AA range: 110-190 |
Caspase-14 Polyclonal Antibody |
ABP50016-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of Caspase-14 from Human. This Caspase-14 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase-14 at AA range: 110-190 |
Caspase-14 Polyclonal Antibody |
ABP50016-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of Caspase-14 from Human. This Caspase-14 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Caspase-14 at AA range: 110-190 |
Caspase-14 Polyclonal Antibody |
ES1015-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against Caspase-14 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Caspase-14 Polyclonal Antibody |
ES1015-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against Caspase-14 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Caspase-14 Polyclonal Antibody |
E20-10023 |
EnoGene |
100ug |
EUR 225 |
Description: Available in various conjugation types. |
Caspase 14 (CASP14) Antibody Pair |
20-abx370399 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
Caspase 14 (CASP14) Antibody Pair |
20-abx370469 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
Caspase-14 recombinant monoclonal antibody |
A5690 |
Bimake |
100ul X 3 |
EUR 714 |
|
Description: A recombinant monoclonal antibody from rabbit against human Caspase-14 for WB, IHC, IF,ELISA |
Caspase-14 |
E8ET1701-52 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
Caspase 14 (CASP14) Polyclonal Antibody (Rat) |
4-PAA457Ra01 |
Cloud-Clone |
-
EUR 291.60
-
EUR 2948.40
-
EUR 735.60
-
EUR 366.00
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14) |
Polyclonal CASP14 / Caspase 14 Antibody (C-Terminus) |
APR02246G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CASP14 / Caspase 14 (C-Terminus). This antibody is tested and proven to work in the following applications: |
Caspase 14 (CASP14) Polyclonal Antibody (Human) |
4-PAA457Hu01 |
Cloud-Clone |
-
EUR 278.40
-
EUR 2742.00
-
EUR 688.80
-
EUR 346.80
-
EUR 249.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14) |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse) |
4-PAA457Mu01 |
Cloud-Clone |
-
EUR 283.20
-
EUR 2805.60
-
EUR 703.20
-
EUR 352.80
-
EUR 250.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14) |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse) |
4-PAA457Mu02 |
Cloud-Clone |
-
EUR 283.20
-
EUR 2805.60
-
EUR 703.20
-
EUR 352.80
-
EUR 250.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14) |
Caspase 14 (p10, Cleaved-Lys222) Antibody |
20-abx015552 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Caspase 14 (p10, Cleaved-Lys222) Antibody |
E11-0148L |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
Caspase 14 (CASP14) Polyclonal Antibody (Rat), PE |
4-PAA457Ra01-PE |
Cloud-Clone |
-
EUR 350.40
-
EUR 3098.40
-
EUR 882.00
-
EUR 439.20
-
EUR 232.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with PE. |
Caspase 12 (Caspase 12) Antibody |
abx231286-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Caspase 12 (Caspase 12) Antibody |
abx432451-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Caspase 12 (Caspase 12) Antibody |
20-abx007974 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Caspase 14 (CASP14) Polyclonal Antibody (Rat), APC |
4-PAA457Ra01-APC |
Cloud-Clone |
-
EUR 408.00
-
EUR 3843.60
-
EUR 1072.80
-
EUR 518.40
-
EUR 260.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with APC. |
Caspase 14 (CASP14) Polyclonal Antibody (Rat), Cy3 |
4-PAA457Ra01-Cy3 |
Cloud-Clone |
-
EUR 493.20
-
EUR 5074.80
-
EUR 1381.20
-
EUR 642.00
-
EUR 297.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with Cy3. |
Caspase 14 (CASP14) Polyclonal Antibody (Rat), HRP |
4-PAA457Ra01-HRP |
Cloud-Clone |
-
EUR 373.20
-
EUR 3350.40
-
EUR 949.20
-
EUR 469.20
-
EUR 246.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with HRP. |
Caspase 14 (CASP14) Polyclonal Antibody (Human), PE |
4-PAA457Hu01-PE |
Cloud-Clone |
-
EUR 334.80
-
EUR 2874.00
-
EUR 825.60
-
EUR 416.40
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with PE. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), PE |
4-PAA457Mu01-PE |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with PE. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), PE |
4-PAA457Mu02-PE |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with PE. |
Caspase 14 (CASP14) Polyclonal Antibody (Rat), FITC |
4-PAA457Ra01-FITC |
Cloud-Clone |
-
EUR 350.40
-
EUR 3098.40
-
EUR 882.00
-
EUR 439.20
-
EUR 232.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with FITC. |
Caspase 14 (CASP14) Polyclonal Antibody (Human), APC |
4-PAA457Hu01-APC |
Cloud-Clone |
-
EUR 387.60
-
EUR 3562.80
-
EUR 1003.20
-
EUR 490.80
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with APC. |
Caspase 14 (CASP14) Polyclonal Antibody (Human), Cy3 |
4-PAA457Hu01-Cy3 |
Cloud-Clone |
-
EUR 468.00
-
EUR 4700.40
-
EUR 1287.60
-
EUR 604.80
-
EUR 286.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with Cy3. |
Caspase 14 (CASP14) Polyclonal Antibody (Human), HRP |
4-PAA457Hu01-HRP |
Cloud-Clone |
-
EUR 356.40
-
EUR 3106.80
-
EUR 889.20
-
EUR 445.20
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with HRP. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), APC |
4-PAA457Mu01-APC |
Cloud-Clone |
-
EUR 394.80
-
EUR 3649.20
-
EUR 1024.80
-
EUR 499.20
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with APC. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), Cy3 |
4-PAA457Mu01-Cy3 |
Cloud-Clone |
-
EUR 476.40
-
EUR 4815.60
-
EUR 1316.40
-
EUR 615.60
-
EUR 289.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with Cy3. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), HRP |
4-PAA457Mu01-HRP |
Cloud-Clone |
-
EUR 362.40
-
EUR 3182.40
-
EUR 907.20
-
EUR 452.40
-
EUR 240.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with HRP. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), APC |
4-PAA457Mu02-APC |
Cloud-Clone |
-
EUR 394.80
-
EUR 3649.20
-
EUR 1024.80
-
EUR 499.20
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with APC. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), Cy3 |
4-PAA457Mu02-Cy3 |
Cloud-Clone |
-
EUR 476.40
-
EUR 4815.60
-
EUR 1316.40
-
EUR 615.60
-
EUR 289.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with Cy3. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), HRP |
4-PAA457Mu02-HRP |
Cloud-Clone |
-
EUR 362.40
-
EUR 3182.40
-
EUR 907.20
-
EUR 452.40
-
EUR 240.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with HRP. |
Caspase 14 (CASP14) Polyclonal Antibody (Human), FITC |
4-PAA457Hu01-FITC |
Cloud-Clone |
-
EUR 334.80
-
EUR 2874.00
-
EUR 825.60
-
EUR 416.40
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with FITC. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), FITC |
4-PAA457Mu01-FITC |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with FITC. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), FITC |
4-PAA457Mu02-FITC |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with FITC. |
Caspase-14 Peptide |
2509P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) Caspase-14 peptide |
Caspase 14 (CASP14) Polyclonal Antibody (Rat), Biotinylated |
4-PAA457Ra01-Biotin |
Cloud-Clone |
-
EUR 368.40
-
EUR 2888.40
-
EUR 856.80
-
EUR 450.00
-
EUR 260.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with Biotin. |
Rabbit Anti Caspase-14 (C-Terminal) Polyclonal Antibody |
CPBT-66307RC |
Creative Diagnostics |
0.1 mg |
EUR 852 |
Caspase 14 (CASP14) Polyclonal Antibody (Human), Biotinylated |
4-PAA457Hu01-Biotin |
Cloud-Clone |
-
EUR 354.00
-
EUR 2682.00
-
EUR 805.20
-
EUR 429.60
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with Biotin. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), Biotinylated |
4-PAA457Mu01-Biotin |
Cloud-Clone |
-
EUR 358.80
-
EUR 2745.60
-
EUR 820.80
-
EUR 435.60
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with Biotin. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), Biotinylated |
4-PAA457Mu02-Biotin |
Cloud-Clone |
-
EUR 358.80
-
EUR 2745.60
-
EUR 820.80
-
EUR 435.60
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with Biotin. |
Caspase 14 (CASP14) Polyclonal Antibody (Rat), APC-Cy7 |
4-PAA457Ra01-APC-Cy7 |
Cloud-Clone |
-
EUR 672.00
-
EUR 7543.20
-
EUR 2002.80
-
EUR 894.00
-
EUR 378.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Caspase 14 (CASP14). This antibody is labeled with APC-Cy7. |
Caspase 14 (CASP14) Polyclonal Antibody (Human), APC-Cy7 |
4-PAA457Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 632.40
-
EUR 6981.60
-
EUR 1862.40
-
EUR 837.60
-
EUR 361.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Caspase 14 (CASP14). This antibody is labeled with APC-Cy7. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), APC-Cy7 |
4-PAA457Mu01-APC-Cy7 |
Cloud-Clone |
-
EUR 645.60
-
EUR 7154.40
-
EUR 1905.60
-
EUR 855.60
-
EUR 364.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with APC-Cy7. |
Caspase 14 (CASP14) Polyclonal Antibody (Mouse), APC-Cy7 |
4-PAA457Mu02-APC-Cy7 |
Cloud-Clone |
-
EUR 645.60
-
EUR 7154.40
-
EUR 1905.60
-
EUR 855.60
-
EUR 364.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Caspase 14 (CASP14). This antibody is labeled with APC-Cy7. |
Human Caspase-14 (CASP14) |
1-CSB-EP004546HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Caspase-14(CASP14) expressed in E.coli |
Caspase 11 Antibody |
20-abx148930 |
Abbexa |
|
|
|
Caspase 7 antibody |
10R-6717 |
Fitzgerald |
100 ug |
EUR 781.2 |
Description: Mouse monoclonal Caspase 7 antibody |
Caspase 8 antibody |
10R-6739 |
Fitzgerald |
100 ug |
EUR 937.2 |
Description: Mouse monoclonal Caspase 8 antibody |
Caspase 4 antibody |
10R-6742 |
Fitzgerald |
100 ug |
EUR 846 |
Description: Mouse monoclonal Caspase 4 antibody |
Caspase 3 antibody |
20R-2495 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal Caspase 3 antibody |
Caspase 8 antibody |
20R-2496 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal Caspase 8 antibody |
Caspase 9 antibody |
20R-2497 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal Caspase 9 antibody |
Caspase 2 antibody |
20R-2898 |
Fitzgerald |
100 ul |
EUR 471.6 |
Description: Rabbit polyclonal Caspase 2 antibody |
Caspase 3 antibody |
20R-CR013 |
Fitzgerald |
50 ug |
EUR 620.4 |
Description: Rabbit polyclonal Caspase 3 antibody |
Caspase 3 Antibody |
21420-100ul |
SAB |
100ul |
EUR 302.4 |
Caspase 3 Antibody |
21420-50ul |
SAB |
50ul |
EUR 224.4 |
Caspase 9 Antibody |
21422-100ul |
SAB |
100ul |
EUR 302.4 |
Caspase 9 Antibody |
21422-50ul |
SAB |
50ul |
EUR 224.4 |
Caspase 9 antibody |
22978-100ul |
SAB |
100ul |
EUR 468 |
Caspase 3 antibody |
20R-1424 |
Fitzgerald |
100 ug |
EUR 937.2 |
Description: Rabbit polyclonal Caspase 3 antibody |
Caspase 9 antibody |
20R-1425 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 9 antibody |
Caspase 1 antibody |
20R-1427 |
Fitzgerald |
100 ug |
EUR 781.2 |
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase 8 antibody |
20R-1428 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 8 antibody |
Caspase 11 antibody |
20R-1429 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 11 antibody |
Caspase 2 antibody |
20R-1431 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 2 antibody |
Caspase 4 antibody |
20R-1432 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 4 antibody |
Caspase 5 antibody |
20R-1433 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 5 antibody |
Caspase 9 antibody |
20R-1468 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 9 antibody |
Caspase 3 antibody |
20R-1469 |
Fitzgerald |
100 ug |
EUR 781.2 |
Description: Rabbit polyclonal Caspase 3 antibody |
Caspase 7 antibody |
20R-1471 |
Fitzgerald |
100 ug |
EUR 937.2 |
Description: Rabbit polyclonal Caspase 7 antibody |
Caspase 9 antibody |
20R-1472 |
Fitzgerald |
100 ug |
EUR 937.2 |
Description: Rabbit polyclonal Caspase 9 antibody |
Caspase 6 antibody |
20R-1476 |
Fitzgerald |
100 ug |
EUR 937.2 |
Description: Rabbit polyclonal Caspase 6 antibody |
Caspase 8 antibody |
20R-1477 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 8 antibody |
Caspase 6 antibody |
20R-1506 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 6 antibody |
Caspase 8 antibody |
20R-1508 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 8 antibody |
Caspase 12 antibody |
20R-1513 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 12 antibody |
Caspase 9 antibody |
20R-1557 |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 9 antibody |
Caspase 10 antibody |
20R-1558 |
Fitzgerald |
200 ug |
EUR 807.6 |
Description: Rabbit polyclonal Caspase 10 antibody |
caspase 1 Antibody |
39310-100ul |
SAB |
100ul |
EUR 468 |
Caspase 6 Antibody |
39238-100ul |
SAB |
100ul |
EUR 468 |
caspase 8 Antibody |
39265-100ul |
SAB |
100ul |
EUR 468 |
Caspase 6 antibody |
70R-30655 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal Caspase 6 antibody |
Electron microscopy additional revealed that left ventricles of pups at PND<em>14</em> after e-cigarette publicity exhibited apoptotic nuclei, convoluted nuclear membranes, myofibrillar derangement, and enlarged mitochondria sometimes displaying indicators of crystolysis, indicative of cardiomyopathy and cardiac dysfunction. Our outcomes present profound adversarial results of prenatal publicity of e-cigarette plus HFD in neonatal hearts that will result in long-term adversarial cardiac penalties within the grownup.